Biotechnology company developing DNA-based medicines.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Inovio Pharmaceuticals, Inc..
The 1 sources with the most insights about Inovio Pharmaceuticals, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
An RRP drug approval was reported and the stock rose sharply. The milestone may improve prospects, but financing needs and commercial potential remain uncertain.
An RRP drug approval was reported and the stock rose sharply. The milestone may improve prospects, but financing needs and commercial potential remain uncertain.
Other assets that creators frequently mention in the same content as Inovio Pharmaceuticals, Inc..
The most active sources covering Inovio Pharmaceuticals, Inc. (INO) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Inovio Pharmaceuticals, Inc. (INO) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Inovio Pharmaceuticals, Inc. (INO) most frequently also discuss INTC, LRCX, MRVL, V, MCO. See the "Discussed alongside" section above for full asset pages.